These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 492425

  • 1. Serum-cholesterol-binding reserve in patients with the nephrotic syndrome.
    Perez GO, Levine S, Gomez E, Hsia SL.
    Nephron; 1979; 24(3):146-9. PubMed ID: 492425
    [Abstract] [Full Text] [Related]

  • 2. Nephrotic origin hyperlipidemia, relative reduction of vitamin E level and subsequent oxidative stress may promote atherosclerosis.
    Skrzep-Poloczek B, Tomasik A, Tarnawski R, Hyla-Klekot L, Dyduch A, Wojciechowska C, Wesolowski W, Kopieczna-Grzebieniak E, Zalejska-Fiolka J, Widera E.
    Nephron; 2001 Sep; 89(1):68-72. PubMed ID: 11528235
    [Abstract] [Full Text] [Related]

  • 3. Serum cholesterol and triglycerides in childhood nephrotic syndrome in northern Nigeria. A preliminary report.
    Abdurrahman MB, Suvarnabai PC, Aikhionbare HA, Timoszyk J.
    Trop Geogr Med; 1984 Mar; 36(1):7-11. PubMed ID: 6729984
    [Abstract] [Full Text] [Related]

  • 4. Hyperlipidemia in childhood idiopathic nephrotic syndrome during initial remission and relapse.
    Mahmud S, Jahan S, Hossain MM.
    Mymensingh Med J; 2011 Jul; 20(3):402-6. PubMed ID: 21804502
    [Abstract] [Full Text] [Related]

  • 5. Serum cholesterol binding reserve and high density lipoprotein cholesterol in patients on maintenance hemodialysis.
    Perez GO, Hsia SL, Christakis G, Burr J.
    Horm Metab Res; 1980 Sep; 12(9):449-54. PubMed ID: 7429416
    [Abstract] [Full Text] [Related]

  • 6. The causal role of hypoalbuminemia in human nephrotic hyperlipidemia.
    Rahman M, Salamatullah Q, Ferdous Z, Hussain MA.
    Bangladesh Med Res Counc Bull; 1976 Jun; 2(1):64-70. PubMed ID: 190998
    [Abstract] [Full Text] [Related]

  • 7. Effect of probucol on hyperlipidemia in patients with nephrotic syndrome.
    Iida H, Izumino K, Asaka M, Fujita M, Nishino A, Sasayama S.
    Nephron; 1987 Jun; 47(4):280-3. PubMed ID: 3696330
    [Abstract] [Full Text] [Related]

  • 8. Studies on the turnover of triglyceride and esterified cholesterol in subjects with the nephrotic syndrome.
    McKenzie IF, Nestel PJ.
    J Clin Invest; 1968 Jul; 47(7):1685-95. PubMed ID: 5658595
    [Abstract] [Full Text] [Related]

  • 9. Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects.
    Vuong TD, Stroes ES, Willekes-Koolschijn N, Rabelink TJ, Koomans HA, Joles JA.
    Kidney Int; 1999 Mar; 55(3):1005-10. PubMed ID: 10027937
    [Abstract] [Full Text] [Related]

  • 10. Decreased serum cholesterol-binding reserve in diabetes mellitus.
    Hsia SL, Fishman LM, Briese FW, Christakis G, Burr J, Bricker LA.
    Diabetes Care; 1978 Mar; 1(2):89-93. PubMed ID: 215396
    [Abstract] [Full Text] [Related]

  • 11. Antithrombin functional activity after a fatty meal in normal subjects, familial hyperlipidemia, and nephrotic syndrome.
    Gomperts ED, Zucker M, Feesey M, Russel D, Salant D, Joffe BI, Mendelsohn D, Seftel H.
    J Lab Clin Med; 1977 Sep; 90(3):529-35. PubMed ID: 578151
    [No Abstract] [Full Text] [Related]

  • 12. [Hyperlipidemia and hyperinsulinemia in kidney diseases occurring with the nephrotic syndrome].
    Razboinikov S, Tishkov I, Shipkova P, Turkolov N, Mushmov D.
    Urol Nefrol (Mosk); 1979 Sep; (4):19-23. PubMed ID: 473433
    [No Abstract] [Full Text] [Related]

  • 13. Hyperlipidaemia in untreated nephrotic syndrome, increased production or decreased removal?
    Chan MK, Persaud JW, Ramdial L, Varghese Z, Sweny P, Moorhead JF.
    Clin Chim Acta; 1981 Dec 24; 117(3):317-23. PubMed ID: 7318185
    [Abstract] [Full Text] [Related]

  • 14. Increased incidence of coronary heart disease associated with combined elevation of serum triglyceride and cholesterol concentrations in the nephrotic syndrome in man.
    Alexander JH, Schapel GJ, Edwards KD.
    Med J Aust; 1974 Jul 27; 2(4):119-22. PubMed ID: 4419153
    [No Abstract] [Full Text] [Related]

  • 15. Albumin synthesis, albuminuria and hyperlipemia in nephrotic patients.
    Kaysen GA, Gambertoglio J, Felts J, Hutchison FN.
    Kidney Int; 1987 Jun 27; 31(6):1368-76. PubMed ID: 3613408
    [Abstract] [Full Text] [Related]

  • 16. Plasma inhibition of lymphocyte proliferation in nephrotic syndrome: correlation with hyperlipidemia.
    Lenarsky C, Jordan SC, Ladisch S.
    J Clin Immunol; 1982 Oct 27; 2(4):276-81. PubMed ID: 7142366
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of lipoprotein lipase by plasma from children with the steroid responsive nephrotic syndrome.
    Vermylen C, Levin M, Barratt TM, Muller DP.
    Pediatr Res; 1987 Aug 27; 22(2):197-200. PubMed ID: 3658546
    [Abstract] [Full Text] [Related]

  • 18. Hypocholesterolemic effect of spirulina in patients with hyperlipidemic nephrotic syndrome.
    Samuels R, Mani UV, Iyer UM, Nayak US.
    J Med Food; 2002 Aug 27; 5(2):91-6. PubMed ID: 12487756
    [Abstract] [Full Text] [Related]

  • 19. Toxicity of lovastatin in rats with experimentally induced nephrotic syndrome.
    Joven J, Vilella E, Camps J, Masana L, Turner PR, Simó JM, Villabona C.
    Nephron; 1990 Aug 27; 56(4):399-404. PubMed ID: 2079999
    [Abstract] [Full Text] [Related]

  • 20. Diffusible fraction of cholesterol in serum of patients with nephrotic syndrome.
    Markiewicz K, Lutz W, Walasek L.
    Acta Med Pol; 1975 Aug 27; 16(3):151-8. PubMed ID: 1180118
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.